PET/MR in Breast Cancer
- 1 July 2015
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 45 (4) , 304-321
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- PET/CT versus body coil PET/MRI: how low can you go?Insights into Imaging, 2013
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2012
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2011
- Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II–III breast cancerEuropean Journal of Cancer, 2010
- The role of FDG PET/CT in patients with locoregional breast cancer recurrence: A comparison to conventional imaging techniquesEuropean Journal of Surgical Oncology, 2010
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast CancerClinical Pharmacology & Therapeutics, 2010
- FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysisJournal of Cancer Research and Clinical Oncology, 2010
- 18F, 64Cu, and 68Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast CancerBioconjugate Chemistry, 2009
- Breast MRI: guidelines from the European Society of Breast ImagingEuropean Radiology, 2008
- A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastasesAnnals of Oncology, 2006